Tocilizumab for the fifth progression of cystic childhood craniopharyngioma—a case report

Tocilizumab for the fifth progression of cystic childhood craniopharyngioma—a case report

We present the case of a 15-year-old girl, with a fifth cystic progression of an adamantinomatous craniopharyngioma after multiple surgeries and previous local radiotherapy. She had severe visual impairment, panhypopituitarism including diabetes insipidus, and several components of hypothalamic dama...

Full description

Bibliographic Details
Main Authors: Evelien de Vos-Kerkhof, Dennis R. Buis, Maarten H. Lequin, Carlien A. Bennebroek, Eleonora Aronica, Esther Hulleman, Nitash Zwaveling-Soonawala, Hanneke M. van Santen, Antoinette Y. N. Schouten-van Meeteren
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-10-01
Series:Frontiers in Endocrinology
Subjects:
adamantinomatous craniopharyngioma
cyst
tocilizumab
visual impairment
hypothalamus
case report
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1225734/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2023.1225734/full

Similar Items